Cargando...
Hematologic Complications of Immune Checkpoint Inhibitors
Immune checkpoint inhibitors have improved outcomes for patients with numerous hematological and solid cancers. Hematologic toxicities have been described, but the spectrum, timing, and clinical presentation of these complications are not well understood. We used the World Health Organization's...
Gardado en:
| Publicado en: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6516131/ https://ncbi.nlm.nih.gov/pubmed/30819785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0574 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|